News
Team
Projects
First Cohort
Second Cohort
Publications
Resources
Events
RTG-Events
Courses
Jobs
Contact
Jennifer Landsberg
Latest
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomas
Cite
×